Cargando…

Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up

Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) is emerging as an effective treatment for patients with symptomatically failing bioprosthetic valves and a high prohibitive surgical risk; a longer life expectancy has led to a higher demand for these valve reinterventions due to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Prandi, Francesca Romana, Niv Granot, Yoav, Margonato, Davide, Belli, Martina, Illuminato, Federica, Vinayak, Manish, Barillà, Francesco, Romeo, Francesco, Tang, Gilbert H. L., Sharma, Samin, Kini, Annapoorna, Lerakis, Stamatios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219453/
https://www.ncbi.nlm.nih.gov/pubmed/37233154
http://dx.doi.org/10.3390/jcdd10050187
_version_ 1785049013842608128
author Prandi, Francesca Romana
Niv Granot, Yoav
Margonato, Davide
Belli, Martina
Illuminato, Federica
Vinayak, Manish
Barillà, Francesco
Romeo, Francesco
Tang, Gilbert H. L.
Sharma, Samin
Kini, Annapoorna
Lerakis, Stamatios
author_facet Prandi, Francesca Romana
Niv Granot, Yoav
Margonato, Davide
Belli, Martina
Illuminato, Federica
Vinayak, Manish
Barillà, Francesco
Romeo, Francesco
Tang, Gilbert H. L.
Sharma, Samin
Kini, Annapoorna
Lerakis, Stamatios
author_sort Prandi, Francesca Romana
collection PubMed
description Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) is emerging as an effective treatment for patients with symptomatically failing bioprosthetic valves and a high prohibitive surgical risk; a longer life expectancy has led to a higher demand for these valve reinterventions due to the increased possibilities of outliving the bioprosthetic valve’s durability. Coronary obstruction is the most feared complication of valve-in-valve (ViV) TAVR; it is a rare but life-threatening complication and occurs most frequently at the left coronary artery ostium. Accurate pre-procedural planning, mainly based on cardiac computed tomography, is crucial to determining the feasibility of a ViV TAVR and to assessing the anticipated risk of a coronary obstruction and the eventual need for coronary protection measures. Intraprocedurally, the aortic root and a selective coronary angiography are useful for evaluating the anatomic relationship between the aortic valve and coronary ostia; transesophageal echocardiographic real-time monitoring of the coronary flow with a color Doppler and pulsed-wave Doppler is a valuable tool that allows for a determination of real-time coronary patency and the detection of asymptomatic coronary obstructions. Because of the risk of developing a delayed coronary obstruction, the close postprocedural monitoring of patients at a high risk of developing coronary obstructions is advisable. CT simulations of ViV TAVR, 3D printing models, and fusion imaging represent the future directions that may help provide a personalized lifetime strategy and tailored approach for each patient, potentially minimizing complications and improving outcomes.
format Online
Article
Text
id pubmed-10219453
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102194532023-05-27 Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up Prandi, Francesca Romana Niv Granot, Yoav Margonato, Davide Belli, Martina Illuminato, Federica Vinayak, Manish Barillà, Francesco Romeo, Francesco Tang, Gilbert H. L. Sharma, Samin Kini, Annapoorna Lerakis, Stamatios J Cardiovasc Dev Dis Review Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) is emerging as an effective treatment for patients with symptomatically failing bioprosthetic valves and a high prohibitive surgical risk; a longer life expectancy has led to a higher demand for these valve reinterventions due to the increased possibilities of outliving the bioprosthetic valve’s durability. Coronary obstruction is the most feared complication of valve-in-valve (ViV) TAVR; it is a rare but life-threatening complication and occurs most frequently at the left coronary artery ostium. Accurate pre-procedural planning, mainly based on cardiac computed tomography, is crucial to determining the feasibility of a ViV TAVR and to assessing the anticipated risk of a coronary obstruction and the eventual need for coronary protection measures. Intraprocedurally, the aortic root and a selective coronary angiography are useful for evaluating the anatomic relationship between the aortic valve and coronary ostia; transesophageal echocardiographic real-time monitoring of the coronary flow with a color Doppler and pulsed-wave Doppler is a valuable tool that allows for a determination of real-time coronary patency and the detection of asymptomatic coronary obstructions. Because of the risk of developing a delayed coronary obstruction, the close postprocedural monitoring of patients at a high risk of developing coronary obstructions is advisable. CT simulations of ViV TAVR, 3D printing models, and fusion imaging represent the future directions that may help provide a personalized lifetime strategy and tailored approach for each patient, potentially minimizing complications and improving outcomes. MDPI 2023-04-23 /pmc/articles/PMC10219453/ /pubmed/37233154 http://dx.doi.org/10.3390/jcdd10050187 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Prandi, Francesca Romana
Niv Granot, Yoav
Margonato, Davide
Belli, Martina
Illuminato, Federica
Vinayak, Manish
Barillà, Francesco
Romeo, Francesco
Tang, Gilbert H. L.
Sharma, Samin
Kini, Annapoorna
Lerakis, Stamatios
Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up
title Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up
title_full Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up
title_fullStr Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up
title_full_unstemmed Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up
title_short Coronary Obstruction during Valve-in-Valve Transcatheter Aortic Valve Replacement: Pre-Procedural Risk Evaluation, Intra-Procedural Monitoring, and Follow-Up
title_sort coronary obstruction during valve-in-valve transcatheter aortic valve replacement: pre-procedural risk evaluation, intra-procedural monitoring, and follow-up
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219453/
https://www.ncbi.nlm.nih.gov/pubmed/37233154
http://dx.doi.org/10.3390/jcdd10050187
work_keys_str_mv AT prandifrancescaromana coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT nivgranotyoav coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT margonatodavide coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT bellimartina coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT illuminatofederica coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT vinayakmanish coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT barillafrancesco coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT romeofrancesco coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT tanggilberthl coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT sharmasamin coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT kiniannapoorna coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup
AT lerakisstamatios coronaryobstructionduringvalveinvalvetranscatheteraorticvalvereplacementpreproceduralriskevaluationintraproceduralmonitoringandfollowup